Chantale Bernatchez

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Intratumoral sotigalimab with pembrolizumab induces rapid activation of antigen presenting cells and drives anti-tumor responses in non-injected tumors in metastatic melanoma: A phase I/II study

  Cancer Discovery · 2026-04-21

• Abstract CT028: Results of first-in-human, Phase 1 study of KSQ-001EX, an autologous tumor infiltrating lymphocyte therapy engineered to inactivate the SOCS1 gene, in patients with select advanced solid tumors

  Cancer Research · 2026-04-17

• Dual-inactivation of Regnase-1 and SOCS1 rewires exhausted CD8 ⁺ T cell fate to enhance anti-tumor functionality

  bioRxiv (Cold Spring Harbor Laboratory) · 2026-01-23 · 3 citations

• Supplementary Figure S3 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma

  2025-11-25

• Supplementary Figure S7 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma

  2025-11-25

• Supplementary Figure S6 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma

  2025-11-25

• Supplementary Figure S1 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma

  2025-11-25

• Supplementary Table 3 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma

  2025-11-25

• Supplementary Tables 1 and 6-8 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma

  2025-11-25

• Supplementary Table 4 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma

  2025-11-25

• Supplementary Figure S4 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma

  2025-11-25

• Supplementary Figure S8 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma

  2025-11-25

• Supplementary Table 5 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma

  2025-11-25

• Supplementary Figure S2 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma

  2025-11-25

• Supplementary Table 2 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma

  2025-11-25

• Supplementary Figure S5 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma

  2025-11-25

• 569 A phase 1/2 study of KSQ-004EX: autologous tumor infiltrating lymphocytes, engineered to inactivate genes encoding SOCS1 and regnase-1, in patients with select advanced solid tumors

  Regular and Young Investigator Award Abstracts · 2025-11-01 · 1 citations

• 1338 Multi-cohort phase II study of autologous centrally manufactured tumor infiltrating lymphocytes

  2025-11-01

• Lymphodepletion, tumor-infiltrating lymphocytes, and high versus low dose IL-2 followed by pembrolizumab in patients with metastatic melanoma

  OncoImmunology · 2025-08-15 · 5 citations

• Intratumoral neutrophil-to-lymphocyte ratio is mirrored by circulating neutrophil-to-lymphocyte ratio in non-small cell lung cancer

  Journal for ImmunoTherapy of Cancer · 2025-06-01 · 5 citations